The Latest Breaking News from AstraZeneca

The monkeypox outbreak theory is just the latest unproven claim to be promoted by the anti-vaxer

While the AZ./Oxford vaccine has all but vanished from richer countries, it has continued to be rolled out elsewhere

As North Korea battles its first known COVID outbreak, a lack of storage, chronic power shortages and inadequately trained medical staff pose acute challenges to inoculating its 25 million people - even with outside help, analysts said.

AstraZeneca plc (NASDAQ:AZN) moved to bolster its COVID-19 portfolio of antibodies with a $157 million licensing deal for experimental therapies developed by newly-launched UK-based biotech, RQ Biotechnology Ltd. In addition to the initial sum, AstraZeneca will pay possible royalty payments as part of the exclusive license to develop pre-clinical COVID antibodies engineered by RQ…

Speaking publicly for the first time, her family say they fully support the COVID-19 vaccine rollout, but believe the government should have had a better plan to support families like theirs.

It means people with aggressive lung cancer can see their life expectancy go from two and half to five years

President Joe Biden will appeal for a renewed international commitment to attacking COVID-19 as the second global COVID-19 summit opens

In recent months there have been positive signs that the world is returning to normal after the Covid-19 pandemic. People have worked tirelessly over the past two years to address and mitigate the consequences of the pandemic, spending billions on healthcare, vaccine development and deployment, social assistance payments, and other…

BALTIMORE — The Maryland-based vaccine maker Emergent BioSolutions was forced to destroy nearly 400 million doses of COVID-19 vaccine because of potential contamination at its East Baltimore plant, far more than previously known.